EXPAREL. An Innovative Non-Opioid Option for the Management of Postsurgical Pain. Presenter s Name Affiliation Date
|
|
- Ada McBride
- 6 years ago
- Views:
Transcription
1 EXPAREL An Innovative Non-Opioid Option for the Management of Postsurgical Pain Presenter s Name Affiliation Date
2 Disclosures The speaker has a consulting relationship with Pacira Pharmaceuticals, Inc. This program is sponsored and approved by Pacira Pharmaceuticals, Inc.
3 A Multimodal Approach Uses a Variety of Therapeutics to Minimize Opioid Use and ORAEs 1-4 Simultaneous use of a combination of 2 analgesics that act at different sites within the central and peripheral nervous systems in an effort to - Reduce pain - Minimize opioid use and ORAEs ORAE, opioid-related adverse event; NSAID, nonsteroidal anti-inflammatory drug; NMDA, N-methyl-D-aspartate; COX, cyclooxygenase. Pain Ascending input via spinothalamic tract Dorsal horn 1. Gottschalk A, Smith DS. Am Fam Physician. 2001;63(10): ; 2. Gandhi K, Viscusi E. The Journal of New York School of Regional Anesthesia. 2009;13:1-10; 3. Kehlet H, Dahl JB. The value of mulitmodal or balanced analgesia in postoperative pain treatment. Anesth Analg. 1993;77(5): ; 4. Yu H, Li Q, Wang D, et al. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fmri). Neurotoxicology. 2012;33(1): Peripheral nerve Tissue Injury Descending modulation Peripheral nociceptors Opioids 1-3 Alpha-2 agonists 1,2 Acetaminophen 2 Anti-inflammatory agents 2 Ketamine 4 Local anesthetics (epidural) 1-3 Opioids 1-3 Alpha-2 agonists 1-3 NMDA antagonists 2 Local anesthetics (peripheral nerve block) 1,2 Local anesthetics (field block) 1-3 NSAIDs 1,2 COX-2 inhibitors 2 Opioids 3
4 Role of Local Anesthetics Act as Membrane Stabilizers rate of depolarization and repolarization of excitable membranes, including nociceptors Inhibit sodium influx through sodium-specific ion channels in the neuronal cell membrane Thus, an action potential cannot arise, and signal conduction is inhibited Techniques for Administering Local Anesthetics Surgical site infiltration 1 Single injection Catheters Peripheral nerve blocks 2 Single injection Catheters Epidural 1. Badner NH, et al. J Bone Joint Surg Am. 1996;78(5): ; 2. Richman JM, et al. Anesth Analg. 2006;102(1):
5 Use of Local Analgesics for Postsurgical Pain Target pain at the source Postsurgical pain is mostly nociceptive pain caused by stimulation of peripheral receptors responding to the surgical insult 1 Infiltrating the surgical site is a simple, effective means of providing analgesia in a variety of surgical procedures 1 Not typically associated with severe side effects 1 Local toxicity, wound infection, and wound healing When delivered in single doses, the duration of traditional local anesthetics can be a limiting factor 2 1. Scott NB. Anaesthesia. 2010;65(Suppl 1):67-75; 2. Gupta A. Curr Opin Anesthesiol. 2010;23(6):
6 EXPAREL: Indicated for Single-Dose Administration Into the Surgical Site to Produce Postsurgical Analgesia Provides long acting pain control with a reduced reliance on opioids 30% reduction in cumulative pain scores and a 45% reduction in opioid consumption No need for catheters or pumps The clinical benefit of the attendant decrease in opioid consumption was not demonstrated EXPAREL is contraindicated in obstetrical paracervical block anesthesia In clinical trials, the most common adverse reactions (incidence 10%) following EXPAREL administration were nausea, constipation, and vomiting
7 EXPAREL Uses DepoFoam to Release Bupivacaine Over Time By utilizing the DepoFoam product delivery platform, EXPAREL delivers therapeutic levels of bupivacaine over time DepoFoam is a multivesicular liposomal product delivery technology that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time 1 DepoFoam utilizes membrane components that are based on natural and well tolerated sources and are cleared by normal metabolic pathways DepoFoam is <3% lipid, biodegradable, and biocompatible 1. Lambert WJ, Los K. In: Rathbone MJ et al, eds. Modified-Release Drug Delivery Technology. Volume 2. 2nd ed. New York: Informa Healthcare; 2008:
8 Pharmacokinetics Demonstrate Plasma Levels of Bupivacaine That Can Persist for 96 Hours 1 Plasma Bupivacaine Concentration (ng/ml) EXPAREL 266 mg Peak P1: 0-2 hours P2: hours Duration 96 hours Second peak due to slow release of bupivacaine from DepoFoam Initial peak largely due to extraliposomal bupivacaine Time (Hours) Other formulations of bupivacaine should not be administered within 96 hours following administration of EXPAREL Systemic plasma levels of bupivacaine following administration of EXPAREL are not correlated with local efficacy The rate of systemic absorption of bupivacaine is dependent upon the total dose of drug administered, the route of administration, and the vascularity of the administration site The blood plasma level for central nervous system effects is 2000 ng/ml The blood plasma level for cardiac effects is 4000 ng/ml 1. Hu D, et al. Clin Drug Investig. 2013;33(22):
9 Clinical Program for FDA Approval Evidence of efficacy and safety with EXPAREL is available from two pivotal Phase 3 trials (one soft tissue and one orthopedic model) The safety of EXPAREL was evaluated in 10 randomized, double-blind, local administration into the surgical site clinical studies involving 823 patients undergoing various surgical procedures including Hemorrhoidectomy Bunionectomy Inguinal hernia repair Breast augmentation Total knee arthroplasty
10 Safety Evaluated in Broad Clinical Development Program 21 clinical studies, 1307 patients received EXPAREL 10 wound infiltration studies: 823 patients Various surgical procedures; EXPAREL doses ranged from 66 mg to 532 mg The maximum dose of EXPAREL should not exceed 266 mg (one 20 ml vial) The most common adverse reactions (incidence 10%) following EXPAREL administration were nausea, constipation, and vomiting Cardiac Safety No QTc prolongation Even at supratherapeutic doses 1 No signal of any clinically important cardiac events from development program Additional Safety Findings No events of chondrolysis No hepatic dosing adjustment for mild to moderate disease No abnormal findings reflecting improper wound healing 2 1. Naseem A, et al. J Clin Pharmacol. 2012;52(9): ; 2. Golf M, et al. Adv Ther. 2011;28(9):
11 Clinical Experience to Date With EXPAREL The safety and efficacy of EXPAREL have only been demonstrated in bunionectomy and hemorrhoidectomy Broad label indication: Used in more than 1,000,000 patients since its launch in April 2012 Soft tissue Bariatric procedures Anorectal procedures Ventral and inguinal herniorrhaphy Open and laparoscopic colorectal procedures Ileostomy reversal Cosmetic plastic surgery: breast augmentation, breast reduction, abdominoplasty Plastic reconstructive surgery Transversus abdominis plane (TAP) infiltration Orthopedic Total knee arthroplasty Total hip arthroplasty Laminectomy Thoracotomy 11
12 Dosing EXPAREL is available as 266 mg, 1.3%/20 ml single-use vials Recommended dose of EXPAREL is based on the surgical site and the volume required to cover the area Dosing is not weight based Maximum dose of EXPAREL should not exceed 266 mg (one 20 ml vial)
13 Administration EXPAREL should be injected slowly into the soft tissues of the surgical site with frequent aspiration to check for blood and minimize the risk of intravascular injection Administer with a 25-gauge or larger needle Following withdrawal from the vial, EXPAREL may be stored at controlled room temperature of 20 C to 25 C (68 F to 77 F) for up to 4 hours prior to administration Soft Tissue Infiltration TAP Infiltration EO=External oblique IO=Internal oblique TA=Transversus abdominis LA=Local anesthetic Adapted from: Journal of New York School of Regional Anesthesia
14 Expanding the Volume The volume of EXPAREL can be expanded as necessary to accommodate administration into a larger surgical site without impacting efficacy EXPAREL can be expanded up to a total volume of 300 ml with normal (0.9%) saline for injection or lactated Ringer s solution Volumes used in clinical practice range from 20 to 300 ml depending on the size of the surgical site
15 Administration Technique Is Important EXPAREL does not diffuse throughout tissues in the same manner as bupivacaine Meticulous infiltration technique is important to ensure best results EXPAREL requires more injections to cover the same area EXPAREL Bupivacaine Note: graphic is for illustrative purposes only.
16 Administration Precautions Wait 20 minutes after administering lidocaine or other nonbupivacaine-based local anesthetics before administering EXPAREL into the same surgical site Allow topical antiseptics to dry before administering EXPAREL into the same surgical site When using bupivacaine HCl before EXPAREL, the dose of bupivacaine HCl should be <50% of the dose of EXPAREL. As a reference: One 20 ml vial of EXPAREL contains 266 mg of free base bupivacaine; 266 mg of free base bupivacaine is equivalent to 300 mg of bupivacaine HCl One 30 ml vial of 0.5% bupivacaine HCl contains 150 mg bupivacaine HCl Toxic effects of these drugs are additive and their administration should be used with caution, including monitoring for neurological and cardiovascular effects related to toxicity
17 Compatibility With Medications and Implantable Materials Commonly Used During Surgery No significant interaction with the following materials: Stainless steel Titanium Polypropylene Silicone Liposomal bupivacaine should not be admixed with other compounds In vivo compatibility studies have not been conducted, but when the following classes of compounds were tested in vitro with EXPAREL they did not cause excessive release of bupivacaine from the liposomal formulation: NSAIDs Opioids Epinephrine Tranexamic acid Corticosteroids Antibiotics Kharitonov V. Postgrad Med. 2014;126(1):
18 Cardiovascular and Central Nervous System Risks Associated With Local Anesthetics As with other local anesthetic products, monitoring of cardiovascular and neurological status, as well as vital signs should be performed during and after injection of EXPAREL The incidences of adverse neurologic reactions associated with the use of local anesthetics may be related to the total dose of local anesthetic administered and are also dependent upon the particular drug used, the route of administration, and the physical status of the patient
19 One Dose of EXPAREL Provides Significant Pain Control With Reduced Opioid Consumption Indicated for administration into the surgical site for postsurgical analgesia Requires no catheter or additional device Supplied in a ready-to-use aqueous suspension or the volume can be expanded to accommodate larger surgical sites Administered using a single-dose deep tissue infiltration technique
20 Important Safety Information EXPAREL is contraindicated in obstetrical paracervical block anesthesia EXPAREL has not been studied for use in patients younger than 18 years of age Non-bupivacaine-based local anesthetics, including lidocaine, may cause an immediate release of bupivacaine from EXPAREL if administered together locally. The administration of EXPAREL may follow the administration of lidocaine after a delay of 20 minutes or more. Other formulations of bupivacaine should not be administered within 96 hours following administration of EXPAREL Monitoring of cardiovascular and neurological status, as well as vital signs should be performed during and after injection of EXPAREL as with other local anesthetic products Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations In clinical trials, the most common adverse reactions (incidence 10%) following EXPAREL administration were nausea, constipation, and vomiting PP-EX-US-0750
BUPIVACAINE LIPOSOME (EXPAREL): Adjunct to Regional Anesthesia
BUPIVACAINE LIPOSOME (EXPAREL): Adjunct to Regional Anesthesia NEBRASKA ASSOCIATION OF NURSE ANESTHETISTS Spring Meeting: April 27-29, 2018 Sallie Poepsel, PhD, MSN, CRNA, APRN Director, AANA Region IV
More informationInnovative Approaches and New Technology to Gain Access
Innovative Approaches and New Technology to Gain Access The following is intended only for presentation to the Reimbursement and Access 2017 audience, August 17, 2017. This information is not for promotional
More informationLiposomal Bupivacaine: A Promising Postop Analgesic for the Future
Review Article imedpub Journals http://www.imedpub.com Medical & Clinical Vol. 1 No. 1: 3 DOI: 10.21767/2471-299X.1000003 Liposomal Bupivacaine: A Promising Postop Analgesic for the Future Abstract Post-operative
More informationHTX-011 Postoperative Pain Program Topline Results from Phase 2b Studies. June 21, 2018
HTX-011 Postoperative Pain Program Topline Results from Phase 2b Studies June 21, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities
More informationDisclosure. Goals: Liposome Bupivacaine (Exparel) 5/12/2016
Liposome Bupivacaine (Exparel) Current Uses and Future Admir Hadzic, MD, Professor of Anesthesiology Director, NAICE (North American Institute for Continuing Education) Director, NYSORA (The New York School
More informationCONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?
CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY? ASK YOUR DOCTOR ABOUT EXPAREL FOR LONG-LASTING, NON-OPIOID PAIN RELIEF. VISIT EXPAREL.com/patient FOR MORE INFORMATION. YOU HAVE A SAY IN HOW YOUR PAIN IS
More informationNerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS
Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV
More informationAnaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation
Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Dr Ajay Kumar Senior Lecturer Macquarie and Melbourne University Introduction Amputee
More informationPacira Corporate Presentation NASDAQ: PCRX. November 2014
Pacira Corporate Presentation NASDAQ: PCRX November 2014 Forward-Looking Statements This presentation contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act
More informationWORRIED ABOUT PAIN AFTER ORAL SURGERY?
WORRIED ABOUT PAIN AFTER ORAL SURGERY? OPIOIDS ARE NOT THE ONLY WAY TO MANAGE PAIN Ask your doctor about opioid-free EXPAREL EXPAREL is indicated for single-dose infiltration in adults to produce postsurgical
More informationAcute Pain Management in the Opioid Tolerant Patient. Objectives. Opioids. The participant will be able to define opioid tolerance
Acute Pain Management in the Opioid Tolerant Patient Kathleen M. Colfer, MSN, RN-BC Clinical Nurse Specialist Acute Pain Management Service Department of Anesthesiology Thomas Jefferson University Hospital
More informationAnesthetic Techniques for Rapid Recovery in Total Knee Arthroplasty
Anesthetic Techniques for Rapid Recovery in Total Knee Arthroplasty Scott T. Ball, MD Chief, Adult Joint Reconstruction Department of Orthopaedic Surgery University of California, San Diego Disclosures
More informationConcerned. Surgery? About Pain After. Talk to Your Doctor About Reducing Postsurgical Pain
Concerned About Pain After Surgery? Talk to Your Doctor About Reducing Postsurgical Pain Will it Hurt? How Will Pain After Surgery Be Treated? If you re about to have surgery or if you re thinking about
More informationCompany Update. August 8, 2018
Company Update August 8, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors
More informationRunning Title: Tandem regional in laparoscopic inguinal herniorrhapy. Disclosures:
The Novel Use of Different Bupivacaine Preparations with Combined Regional Techniques for Postoperative Pain Management in Non Opioid Based Laparoscopic Inguinal Herniorrhaphy Andrew C. Eppstein (MD) a
More informationCompany Update. June 24, 2018
Company Update June 24, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors
More informationCurrent evidence in acute pain management. Jeremy Cashman
Current evidence in acute pain management Jeremy Cashman Optimal analgesia Best possible pain relief Lowest incidence of side effects Optimal analgesia Best possible pain relief Lowest incidence of side
More informationHTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Bunionectomy
HTX-011, a Proprietary, Unique, Long-Acting Local Anesthetic, Reduces Acute Postoperative Pain Intensity and Opioid Consumption Following Bunionectomy Eugene Viscusi, 1 Oscar DeLeon-Casasola, 2 TJ Gan,
More informationManagement of Acute Pain in the Chronic Pain Patient. Eric Cannon, MD Mountain West Anesthesia December 1, 2017
Management of Acute Pain in the Chronic Pain Patient Eric Cannon, MD Mountain West Anesthesia December 1, 2017 Objectives 1. Describe the unique challenges of managing acute pain episodes in patients being
More informationPerioperative Pain Management
Perioperative Pain Management Overview and Update As defined by the Anesthesiologist's Task Force on Acute Pain Management are from the practice guidelines from the American Society of Anesthesiologists
More informationUse of Liposomal Bupivacaine in Major Foot and Ankle Surgery
Use of Liposomal Bupivacaine in Major Foot and Ankle Surgery Chris Adair MD, Bruce Cohen MD, Robert Anderson MD, W Hodges Davis MD, Carroll Jones MD, Kent Ellington MD Disclosures: Chris Adair, MD: None
More informationENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT
ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT Jeff Gadsden, MD, FRCPC, FANZCA Associate Professor Duke University Department of Anesthesiology Regional Anesthesia and Acute Pain Medicine DISCLOSURES
More informationCONTRAINDICATIONS EXPAREL is contraindicated in obstetrical paracervical block anesthesia (4).
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EXPAREL safely and effectively. See full prescribing information for EXPAREL. EXPAREL (bupivacaine
More information2018 Learning Outcomes
I. Pain Physiology and Anatomy (20%) A. Describe the basic anatomy of the nervous system. B. Describe the physiological mechanisms of neuronal function (eg- action potentials). C. Review the nociceptive
More informationEfficacy and Safety of Sublingual Sufentanil 30 mcg for the Management of Acute Pain Following Ambulatory Surgery. Pamela P.
Efficacy and Safety of Sublingual Sufentanil 30 mcg for the Management of Acute Pain Following Ambulatory Surgery Pamela P. Palmer, MD, PhD Disclosures for Dr. Pamela Palmer AcelRx employee Currently own
More informationIntravenous lidocaine infusions. Dr Ian McConachie FRCA FRCPC
Intravenous lidocaine infusions Dr Ian McConachie FRCA FRCPC Thank the organisers for inviting me. No conflicts or disclosures Lidocaine 1 st amide local anesthetic Synthesized in 1943 by Lofgren in Sweden.
More informationWITH ISOBARIC BUPIVACAINE (5 MG/ML)
, 49, 2013, 3 63 (5 MG/ML) (5 MG/ML).,.,.,..,..,, SPINAL ANESTHESIA: COMPARISON OF ISOBARIC ROPIVACAINE (5 MG/ML) WITH ISOBARIC BUPIVACAINE (5 MG/ML) D. Tzoneva, Vl. Miladinov, Al. Todorov, M. P. Atanasova,
More informationHTX-011 Postoperative Pain Program Topline Results From Phase 3. March 19, 2018
HTX-011 Postoperative Pain Program Topline Results From Phase 3 March 19, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation
More informationObjectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE
Optimizing Analgesia to Enhance the Recovery After Surgery Francesco Carli, M.D.. McGill University, Montreal, QC, Canada. ASPMN, Baltimore, 2012 CME FACULTY DISCLOSURE Francesco Carli has no affiliation
More informationPERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE?
PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE? Sandra Z Perkowski, VMD, PhD, DACVAA University of Pennsylvania, School of Veterinary Medicine, Philadelphia, PA Pre-emptive and multimodal use
More informationEmerging roles of liposomal bupivacaine in anesthesia practice
Review Article Emerging roles of liposomal bupivacaine in anesthesia practice Obaid Malik, Alan D. Kaye 1, Aaron Kaye 1, Kumar Belani 2, Richard D. Urman 3 Department of Anesthesia, Critical Care and Pain
More informationNew Methods for Analgesia Delivery
New Methods for Analgesia Delivery Guy Ludbrook MBBS PhD FANZCA Royal Adelaide Hospital and University of Adelaide South Australia Anesthesiology is on the verge of a major evolution that will involve
More informationWhat s New in Post-Cesarean Analgesia?
Anesthesia & Obstetrics What s New in Post-Cesarean Analgesia? October 23rd, 2013 2013 UCSF What Does The Evidence Tell Us? Mark Rollins, MD, PhD UC SF Post-Delivery Pain (Mean pain scores for first 24
More informationPost Caesarean Analgesia An Update. Kim Ekelund MD, PhD, associate professor Rigshospitalet Copenhagen, Denmark
Post Caesarean Analgesia An Update Kim Ekelund MD, PhD, associate professor Rigshospitalet Copenhagen, Denmark Post caesarean analgesia No Conflicts of Interests Neuraxial opioids Multimodal therapy Plan
More informationINGUINAL HERNIOTOMY Updated by Narinder Rawal
Sistla SC, Sibal AK, Ravishankar M. Intermittent wound perfusion for postoperative pain relief following upper abdominal surgery: a surgeon s perspective. Pain Practice 2009;9:65 70. Sorbello M, Paratore
More informationPre-op Interventions to Mitigate Post-op Acute and Chronic Pain
Pre-op Interventions to Mitigate Post-op Acute and Chronic Pain H A R S H A S H A N T H A N N A. M D, M S C A S S O C I A T E P R O F E S S O R D E P A R T M E N T O F A N E S T H E S I A C H R O N I C
More informationAnalgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital
Analgesia for ERAS programs Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital Disclosure I have received honoraria from Mundipharma and MSD The new Wagga Wagga Rural Referral Centre Scope Analgesic
More informationContinuous Wound Infusion and Postoperative Pain Current status?
Continuous Wound Infusion and Postoperative Pain Current status? Pr Patricia Lavand homme Department of Anesthesiology St Luc Hospital University Catholic of Louvain Medical School Brussels, Belgium Severe
More informationImproving acute pain care with multimodal analgesia. Sponsored by Mallinckrodt Pharmaceuticals.
Improving acute pain care with multimodal analgesia Discussion topics Section 1 Opioid monotherapy and the state of acute pain management Section 2 Multimodal analgesia for balanced acute pain management
More informationPOST-OP MULTIMODAL PAIN MANAGEMENT. Maripat Welz-Bosna Reading Hospital Medical Center Department of Medicine Hospitalist Services/Pain Management
POST-OP MULTIMODAL PAIN MANAGEMENT Maripat Welz-Bosna Reading Hospital Medical Center Department of Medicine Hospitalist Services/Pain Management Objectives Understand the basic neurobiology of the pain
More informationThe Fifth Vital Sign.
Recognizing And Monitoring The Painful Patient Susan Clark, LVT, VTS(ECC) The Fifth Vital Sign. Pain control is part of the accepted standard of care in veterinary medicine. The ability to recognize the
More informationFASCIAL PLANE BLOCKS TOM BARIBEAULT MSN, CRNA
FASCIAL PLANE BLOCKS TOM BARIBEAULT MSN, CRNA TECHNIQUES Abdominal Wall TAP Rectus Sheath Quadratus Lumborum Erector Spinae Chest PECS I & II Erector Spinae TECHNIQUES Knee Ipack/LIA Hip Fascia Iliaca
More informationPotential Utility of Liposome Bupivacaine in Orthopedic Surgery
Potential Utility of Liposome Bupivacaine in Orthopedic Surgery Am J Orthop. 2015 February;44(2):111-117 Authors: Lonner JH Scuderi GR Lieberman JR Author Affiliation Disclosures Jess H. Lonner, MD, Giles
More informationBalanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D
Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor
More informationWelcome Charles Kennedy
Welcome Charles Kennedy Comoderators Girish P. Joshi, MBBS, MD, FFARCI Professor of Anesthesiology and Pain Management University of Texas Southwestern Medical Center Dallas, Texas David E. Beck, MD, FACS
More informationRECENT ADVANCES IN ANALGESIA
4th ERAS UK Conference RECENT ADVANCES IN ANALGESIA Dr William J Fawcett Royal Surrey County Hospital, Guildford University of Surrey, Guildford November 14th 2014 Conflict of interests Paid honoraria
More informationPost-operative Analgesia for Caesarean Section
Post-operative Analgesia for Caesarean Section Introduction Good quality analgesia after any surgery leads to earlier mobilisation, fewer pulmonary and cardiac complications, a reduced risk of DVT and
More informationLearning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16
Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center
More informationEvaluation of the Effect of Magnesium Sulphate as Adjunct to Epidural Bupivacaine: An Institutional Based Study
Original article: Evaluation of the Effect of Magnesium Sulphate as Adjunct to Epidural Bupivacaine: An Institutional Based Study RajulSubhash Karmakar 1, ShishirRamachandra Sonkusale 1* 1Associate Professor,
More informationNon-Narcotic Pain Management Strategies in Post-Operative Patients
Non-Narcotic Pain Management Strategies in Post-Operative Patients Danielle Tompkins, PharmD University of Illinois at Chicago, College of Pharmacy PGY2 Critical Care Pharmacy Resident 1 Conflicts of Interest
More informationOpioids and Respiratory Depression
Opioids and Respiratory Depression Clinical Committee Society of Anesthesia and Sleep Medicine https://commons.wikimedia.org/wiki/file:mu_opioid_receptor.svg Introduction Opioid-induced respiratory depression
More informationANALGESIA and LOCAL ANAESTHESIA. Professor Donald G. MacLellan Executive Director Health Education & Management Innovations
ANALGESIA and LOCAL ANAESTHESIA Professor Donald G. MacLellan Executive Director Health Education & Management Innovations Definition of Pain Pain is an unpleasant sensory and emotional experience with
More informationSEEING KETAMINE IN A NEW LIGHT
SEEING KETAMINE IN A NEW LIGHT BobbieJean Sweitzer, M.D., FACP Professor of Anesthesiology Director of Perioperative Medicine Northwestern University Bobbie.Sweitzer@northwestern.edu LEARNING OBJECTIVES
More informationAdjuvants for peripheral nerve blocks. Daan Bringmans
Adjuvants for peripheral nerve blocks Daan Bringmans Why adjuvants in peripheral nerve blocks? increase speed of onset increase duration of action increase density or quality of block decrease toxicity
More informationInpatient Management of Trauma Related Pain
Inpatient Management of Trauma Related Pain STOMP Summit September 9, 2016 Ann O Rourke, MD, MPH University of Wisconsin Department of Surgery 1 Our patient Small SDH Intubated Hemopneumothorax with multiple
More informationOFIRMEV a non-opioid, non-nsaid, intravenous analgesic for the management of pain
FOR PHARMACY PROFESSIONALS In pharmacokinetic studies Rapid time to reach Cmax with IV acetaminophen OFIRMEV from the start OFIRMEV g demonstrated early and high Cmax at minutes Consider administering
More informationSpinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018
Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive
More informationCorporate Update. November 27, 2018
Corporate Update November 27, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors
More informationMr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government
Mr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government Introduction Brief update Two main topics Use of Gabapentin Local Infiltration Analgesia
More informationALVIMOPAN 0.0 OVERVIEW
ALVIMOPAN 0.0 OVERVIEW A. Alvimopan is a peripherally restricted mu-opioid receptor antagonist. B. DOSING INFORMATION : For the treatment of opioid bowel dysfunction, oral alvimopan doses between 0.5 milligrams
More informationEffective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1
Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1 Fast onset of pain relief with 7% reduction in visual analog scale (VAS) scores
More informationWhat do we want for pain medications?
New Trends in Pain Pharmacotherapy Dr. Chi Wai Cheung MBBS(HK), FHKCA, FHKAM(Anaesthesiology), Dip Pain Mgt(HKCA) Clinical Assistant Professor Department of Anaesthesiology The University of Hong Kong
More informationAdvancement in the use of multimodal analgesia for acute postoperative pain
Advancement in the use of multimodal analgesia for acute postoperative pain Ratan K. Banik, M.D., Ph.D. Assistant Professor Department of Anesthesiology University of Minnesota, Minneapolis, USA 4 October
More informationHussein M. 1*, Youssef K. 2 and Hassan M. 2.
Comparative Study between Continuous Transversus Abdominis Plane Block and ON- Q Anesthetic Pump for Postoperative Analgesia Following Caesarean Section Hussein M. 1*, Youssef K. 2 and Hassan M. 2 1 Department
More informationCase 1:15-cv LAK Document 45 Filed 12/15/15 Page 1 of 36
Case 1:15-cv-07055-LAK Document 45 Filed 12/15/15 Page 1 of 36 Case 1:15-cv-07055-LAK Document 45 Filed 12/15/15 Page 2 of 36 Case 1:15-cv-07055-LAK Document 45 Filed 12/15/15 Page 3 of 36 Case 1:15-cv-07055-LAK
More informationAVENUE THERAPEUTICS, INC. NASDAQ: ATXI JANUARY 2018
AVENUE THERAPEUTICS, INC. NASDAQ: ATXI JANUARY 2018 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward-looking statements within the meaning
More informationFrederic J., Gerges MD. Ghassan E. Kanazi MD., Sama, I. Jabbour-Khoury MD. Review article from Journal of clinical anesthesia 2006.
Frederic J., Gerges MD. Ghassan E. Kanazi MD., Sama, I. Jabbour-Khoury MD. Review article from Journal of clinical anesthesia 2006 Introduction Laparoscopic surgery started in the mid 1950s. In recent
More informationDORIS DUKE MEDICAL STUDENTS JOURNAL Volume V,
Continuous Femoral Perineural Infusion (CFPI) Using Ropivacaine after Total Knee Arthroplasty and its Effect on Postoperative Pain and Early Functional Outcomes Eric Lloyd Scientific abstract Total Knee
More informationCase Report Treatment of Digital Ischemia with Liposomal Bupivacaine
Case Reports in Anesthesiology, Article ID 853243, 4 pages http://dx.doi.org/10.1155/2014/853243 Case Report Treatment of Digital Ischemia with Liposomal Bupivacaine José Raul Soberón, 1 Scott F. Duncan,
More informationAcute Postoperative Pain. David Radvinsky, MD March 24, 2016
Acute Postoperative Pain David Radvinsky, MD March 24, 2016 Objectives 1. Discuss the multimodal approach to pain management and discuss the various classes of drugs based on receptor mechanism. 2. Give
More informationTable of Contents. 1 Introduction NOCITA Efficacy... 15
Technical Monograph Table of Contents 1 Introduction...2 6 NOCITA Efficacy... 15 Overview of Postoperative Pain Management...2 Canine Pilot Field Study... 15 Science of Nociception...3 Canine Pivotal Field
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress REDUCING THE PAIN FACTOR AN UPDATE ON PERI-OPERATIVE ANALGESIA Sandra Forysth, BVSc DipACVA Institute of Veterinary,
More informationIntrathecal Infusion Therapy for Chronic Pain: Challenges, Lessons and Opportunities
June 14-15, 2016 Mult imodal Therapies for Brain Disorders: A Workshop Hosted by: Forum on Neuroscience and Nervous System Disorders Intrathecal Infusion Therapy for Chronic Pain: Challenges, Lessons and
More informationInitiating Labour Analgesia in 2020: Predicting the Future Epidurals, CSEs, Spinal Catheters, Epidrum & Epiphany
Initiating Labour Analgesia in 2020: Predicting the Future Epidurals, CSEs, Spinal Catheters, Epidrum & Epiphany Kenneth E Nelson, M.D. Associate Professor Wake Forest University, North Carolina, USA Initiating
More informationEnhanced recovery after surgery, which involves implementation
Special Topic Surgical Site Infiltration for Abdominal Surgery: A Novel Neuroanatomical-based Approach Girish P. Joshi, MBBS, MD, FFARCSI* Jeffrey E. Janis, MD, FACS Eric M. Haas, MD, FACS, FASCRS Bruce
More information5 th ERAS UK Conference. Advances in Pain Management. Jayne Balson Advanced Nurse Specialist Pain Management Western General Hospital Edinburgh
5 th ERAS UK Conference Advances in Pain Management Jayne Balson Advanced Nurse Specialist Pain Management Western General Hospital Edinburgh Pre-op information Optimised organ function No nutritional
More informationINTRAVENOUS LIDOCAINE INFUSIONS AND INTRALIPID RESCUE
INTRAVENOUS LIDOCAINE INFUSIONS AND INTRALIPID RESCUE Acute Pain Service-LHSC VH and UH sites HISTORY Lidocaine and procaine used by IV infusion in the 1950s and 1960s for general analgesia Often continued
More informationThe Role of Ketamine in the Management of Complex Acute Pain
The Role of Ketamine in the Management of Complex Acute Pain Dr James Bennett Consultant Anaesthetist Consultant Lead for Inpatient Pain Service East Sussex Healthcare NHS Trust STAPG Committee Member
More informationProfessor Narinder Rawal, MD, PhD, FRCA (Hon), EDRA Department of Anaesthesiology and Intensive Care University Hospital Örebro, Sweden
Professor Narinder Rawal, MD, PhD, FRCA (Hon), EDRA Department of Anaesthesiology and Intensive Care University Hospital Örebro, Sweden Infiltrative techniques in perioperative pain lecture outline Why
More informationGastrointestinal and urinary complications in the postoperative period
The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida Gastrointestinal and urinary complications in the postoperative period Dan Hunt, MD Professor of Medicine Director, Division of Hospital
More informationNew Kids on the Block: Advances in Regional Anesthesia Practice. Melissa Byrne DO,
New Kids on the Block: Advances in Regional Anesthesia Practice Melissa Byrne DO, MPH @dr_melissabyrne Precision Acute Care Medicine Chronic Pain Nurse, get on the internet, go to NYSORA.COM, scroll
More informationThe effect of liposomal bupivacaine injection during total hip arthroplasty: a controlled cohort study
Domb et al. BMC Musculoskeletal Disorders 2014, 15:310 RESEARCH ARTICLE Open Access The effect of liposomal bupivacaine injection during total hip arthroplasty: a controlled cohort study Benjamin G Domb
More informationCAESAREAN SECTION Brian Fredman
CHAPTER 3 GYNAECOLOGICAL SURGERY CAESAREAN SECTION Brian Fredman Review of evidence: surgical site infusion Of the seven studies on surgical site local anaesthetic infusion after Caesarean section performed
More informationFrom preemptive to preventive analgesia Esther M. Pogatzki-Zahn and Peter K. Zahn
From preemptive to preventive analgesia Esther M. Pogatzki-Zahn and Peter K. Zahn Purpose of review Much effort has been taken to prove that a treatment initiated before surgery is more effective in reducing
More informationEfficacy of Transversus Abdominis Plane Block versus Epidural Analgesia in Pain Management Following Lower Abdominal Surgery
Med. J. Cairo Univ., Vol. 85, No. 6, September: 2231-2235, 2017 www.medicaljournalofcairouniversity.net Efficacy of Transversus Abdominis Plane Block versus Epidural Analgesia in Pain Management Following
More informationLOCAL ANESTHETIC NERVE BLOCKS and ANALGESIA. Carolyn Cartwright, RVT, VTS (Anesthesia/Analgesia)
LOCAL ANESTHETIC NERVE BLOCKS and ANALGESIA Carolyn Cartwright, RVT, VTS (Anesthesia/Analgesia) Effective approach for optimum pain management requires a practical multimodal anesthesia and analgesia protocol.
More informationShow Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital
Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Overview Review overall (ERAS and non-eras) data for EA, PVB, TAP Examine
More informationPAIN COMFORT NO PAIN AFTER SURGERY. Simplifying post-surgical pain management with a multimodal strategy PRESENTED BY:
PAIN COMFORT NO PAIN AFTER SURGERY Simplifying post-surgical pain management with a multimodal strategy PRESENTED BY: How much will it hurt after surgery? When you re about to undergo surgery, it can be
More informationPAEDIATRIC NERVE BLOCK / WOUND INFILTRATION
PAEDIATRIC NERVE BLOCK / WOUND INFILTRATION Addendum to the MULTIDISCIPLINARY GUIDELINES FOR ACUTE PAIN MANAGEMENT IN CHILDREN AND YOUNG PEOPLE Policy Owner: Approved by: Ratified by: ABMU HB Pain Management
More informationFast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH
Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus
More informationThe TAP Block: Rapidly Evolving From Managing Acute Post-Op Pain to Treating Chronic Abdominal Pain
Interventional APRIL 9, 2018 The TAP Block: Rapidly Evolving From Managing Acute Post-Op Pain to Treating Chronic Abdominal Pain By Anil P. Pisharoty, MD Purpose This review article describes the increasing
More informationPersistent post surgical pain. Jim Olson Waitemata DHB Auckland
Persistent post surgical pain Jim Olson Waitemata DHB Auckland Declaration Within the last five years I have accepted hospitality from the pharmaceutical industry, received honoraria from Mundipharma NZ
More informationCore Safety Profile. Date of FAR:
Core Safety Profile Active substance: Levobupivicaine Pharmaceutical form(s)/strength: Solution for injection, concentrate for solution for infusion, 2,5 mg/ml, 5 mg/ml, 7,5 mg/ml, 0,625 mg/ml, 1,25 mg/ml
More informationNEW KIDS ON THE BLOCK: THE NEW ERA OF REGIONAL ANESTHESIA PLANE BLOCKS
2017 CSA Fall Anesthesia Conference NEW KIDS ON THE BLOCK: THE NEW ERA OF REGIONAL ANESTHESIA PLANE BLOCKS Michael Barrington, MB BS, FANZCA, PhD Senior Staff Anaesthetist, St Vincent s Hospital, Melbourne.
More informationDr David Uncles. Consultant Anaesthetist Western Sussex Hospitals NHS Trust Worthing Hospital, Worthing, West Sussex
Dr David Uncles Consultant Anaesthetist Western Sussex Hospitals NHS Trust Worthing Hospital, Worthing, West Sussex STAPG Annual Conference 12th November 2012 Declaration I have assisted the pharmaceutical
More informationJournal of Women's Health, Gynecology & Obstetrics
Journal of Women's Health, Gynecology & Obstetrics Research Article Raafat TA and Serry MM. J Wom Pethidine Infiltration in Intra Fascial Layer After Abdominal Hysterectomy Tarek Aly Raafat 1*, Mostafa
More informationCompany Update. M ARCH 27 th, 2018
Company Update M ARCH 27 th, 2018 Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors
More informationPain Management in the Surgical Patient. Peter Vogel, VMD, DACVS
Pain Management in the Surgical Patient Peter Vogel, VMD, DACVS Pain Pathways u Specialized neurons that travel through the spinal cord u Free nerve endings in skin, connective tissue, muscle and bone
More informationThe use of Pudendal Nerve Block in Hemorrhoidectomy Operations: A Prospective Double Blind Placebo Control Study
Kasr El Aini Journal of Surgery VOL., 10, NO 3 September 2009 97 The use of Pudendal Nerve Block in Hemorrhoidectomy Operations: A Prospective Double Blind Placebo Control Study Sherif Adly and Mohamed
More information